72,234 articles
J. Wade Harper
J. Wade Harper is an American cell biologist at Harvard Medical School, known for co-discovering cullin-RING ubiquitin ligases and for work on mitophagy in Parkinson's disease.
J. Warren Harthorne
J. Warren Harthorne is an American cardiologist, Professor of Medicine Emeritus at Harvard Medical School and a longtime Massachusetts General Hospital cardiologist, known for cardiac pacing and coronary angiography.
J. Warren Perry
J. Warren Perry (1921–2010) was an American health professions educator and psychologist who served as founding dean of the School of Health Related Professions at the University at Buffalo.
J. Wayne Streilein
J. Wayne Streilein (1935–2004) was an American immunologist who showed that immune privilege in the eye is actively maintained suppression, and was president of Schepens Eye Research Institute in Boston.
J. William Harbour
J. William Harbour is an American ophthalmologist and ocular oncologist who chairs ophthalmology at UT Southwestern Medical Center and developed the standard prognostic test for uveal melanoma.
J. William Langston
J. William Langston is an American neurologist who identified the toxin MPTP as a cause of parkinsonism in 1982 and founded the Parkinson's Institute in Sunnyvale, California.
J. Woodland Hastings
J. Woodland Hastings (1927–2014) was an American biochemist at Harvard University who established bioluminescent organisms, above all the dinoflagellate Gonyaulax, as model systems for circadian biology.
J.A. Stockman
J.A. Stockman, also known as James A. Stockman, is an American pediatric hematologist-oncologist whose New England Journal of Medicine work defined the anemia of prematurity and sickle-cell stroke.
J.E. Folk
J.E. Folk, John E. Folk (1925–2010), was an American biochemist at the National Institutes of Health who discovered the hypusine modification of eIF5A, essential for cell growth.
J.F. Pantridge
J.F. Pantridge, known as Frank Pantridge, was a Northern Irish cardiologist who built the first portable defibrillator and started the world's first prehospital cardiac care unit in Belfast in 1966.
J.G. Heathcote
J.G. Heathcote is a British biochemist who researched oral vitamin B12 treatment of pernicious anemia at St Helens Hospital and the University of Salford, publishing from 1958 to 1976.
J.G. Seidman
J.G. Seidman, or Jonathan G. Seidman, is a human molecular geneticist and professor of genetics at Harvard Medical School known for identifying genes that cause hypertrophic cardiomyopathy and congenital heart defects.
J.H.D. Cate
J.H.D. Cate, also known as Jamie H. D. Cate, is an American structural biologist at UC Berkeley known for crystal structures of the bacterial ribosome.
J.J. Skehel
J.J. Skehel, also known as John J. Skehel, is an English virologist who determined the three-dimensional structure of influenza haemagglutinin and directed London's NIMR from 1987 to 2006.
J.J.G. Tesmer
J.J.G. Tesmer, also known as John J.G. Tesmer, is an American structural biologist at Purdue University known for determining atomic structures of GPCR signaling proteins.
J.L. Burton
J.L. Burton, or John Lloyd Burton, was a British dermatologist at the University of Bristol known for research on sebaceous glands and skin lipid biochemistry.
J.L. Hamerton
J.L. Hamerton, full name John Laurence Hamerton, was a British-born cytogeneticist who headed Human Genetics at the University of Manitoba and co-authored the 1956 paper fixing the human chromosome count at 46.
J.M. Walshe
John Michael Walshe (1920–2022) was a British physician-scientist in hepatology at Cambridge and University College Hospital who discovered the three main drug treatments for Wilson's disease.
J.N. Blau
J.N. Blau, Joseph Norman ('Nat') Blau (1928–2010), was a British neurologist and migraine specialist who co-founded the City of London Migraine Clinic and identified migraine's pre-headache prodrome.
J.N. Morris
J.N. Morris, born Jeremiah Noah Morris and known as Jerry Morris, was a British physician and epidemiologist whose 1953 London busmen study first linked physical activity to heart disease.
J.R.A. Mitchell
J.R.A. Mitchell, John Richard Anthony Mitchell (1928–1991), was a British cardiologist and the first clinical professor of the University of Nottingham medical school, known for platelet research.
J.S. Elborn
J. Stuart Elborn, known as Stuart Elborn, is a Northern Irish respiratory physician-scientist known for cystic fibrosis trials and for founding Belfast's Regional Adult Cystic Fibrosis Centre.
J.W.M. van der Meer
J.W.M. van der Meer, also known as Jos W.M. van der Meer, is a Dutch physician-immunologist and emeritus professor of medicine at Radboud University Nijmegen, known for the trained-immunity paradigm.
J82
J82 (CVCL_0359, ATCC HTB-1) is a human bladder transitional cell carcinoma cell line from a 58-year-old Swedish male donor, TP53/PTEN/RB1-mutant, with a documented historical T24 cross-contamination issue.
Jaakko Perheentupa
Jaakko Perheentupa is a Finnish pediatrician who co-defined the Finnish disease heritage in 1973 and first described Mulibrey nanism, lysinuric protein intolerance, and cartilage-hair hypoplasia.
Jaakko Tuomilehto
Jaakko Tuomilehto is a Finnish epidemiologist and professor emeritus at the University of Helsinki known for the Finnish Diabetes Prevention Study and the FINDRISC risk score.
Jaap de Roode
Jaap de Roode, born Jacobus C. de Roode, is a Dutch evolutionary biologist at Emory University who showed that monarch butterflies medicate their offspring against parasites.
Jaap Goudsmit
Jaap Goudsmit, born 1951 in Amsterdam, is a Dutch virologist and epidemiologist known for AIDS research in the Amsterdam cohort, broadly neutralizing influenza antibodies, and leadership at Crucell and Harvard.
Jaap Verweij
Jaap Verweij is a Dutch medical oncologist, Emeritus Professor and former Dean at Erasmus MC, Rotterdam, known for the EORTC high-dose imatinib trials in GIST and sarcoma drug development.
JAB-23E73, pan-KRAS inhibitor
JAB-23E73 is an investigational oral pan-KRAS inhibitor developed by Jacobio Pharmaceuticals, in phase I testing for advanced solid tumors with KRAS mutations in China and the United States.